Showing 1 - 7 of 7
We study the structure of the interregional inventor networks in Sweden by examining the residence of inventors and …
Persistent link: https://www.econbiz.de/10008764071
We analyze the frequency and nature by which new firms are acquired by established businesses. Acquisitions are often considered to reflect a technology transfer process and to also constitute one way in which a “symbiosis” between new technology-based firms (NTBFs) and established...
Persistent link: https://www.econbiz.de/10010945043
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10005077278
, focusing on the relation between institutions and innovation practices and taking into account the diversity of actors …
Persistent link: https://www.econbiz.de/10010818687
This study investigates the determinants of R&D expenditures in the Swedish pharmaceutical industry from the 1960s to the mid 1990s. Various proxies for the rate of return of R&D (e.g. expected profit, sales and R&D productivity) as well as the availability of internal funding (proxied by past...
Persistent link: https://www.econbiz.de/10008764489
firms located in agglomerations or industrial clusters. This paper investigates the extent to which innovative firms in …
Persistent link: https://www.econbiz.de/10011105519
We use longitudinal, disease-level data to analyze the impact of pharmaceutical innovation on longevity and medical … expenditure in Sweden, where mean age at death increased by 1.88 years during the period 1997-2010. Pharmaceutical innovation is … the number of drugs to treat a disease, not the number of drug classes. Pharmaceutical innovation also reduced hospital …
Persistent link: https://www.econbiz.de/10010569681